Genes & Health: NGO against COVID-19 Non-funding Support
Entity: Genes & Health
Category: Non-funding support
Description: One of the world’s largest community-based genetics studies, aiming to improve health among people of Pakistani and Bangladeshi heritage by analysing the genes and health of 100,000 local people. Genes & Health is a not-for-profit project.
1 Project.
The COVID-19 Host Genetics Initiative
Summary:
Genes & Health is a Partner of the global project "The COVID-19 Host Genetics Initiative".
In the framework of this project, the following study is being carried out:
Author: David van Heel
Research question: Our main research interest is a very early GWAS of severe covid cases. To address the question: does host genetics influence why a few get very severe disease, whereas many get aysymptomatic or mild disease?
Study design: 28675 existing Illumina GSAv3EA+MD genotyped (post QC) volunteers of British south Asian ethnicity. 5000 of these also whole exome sequenced. We will identify which of these touch UK hospital systems in real time. Data will include inpatient status and health record collected clinical details, pathology (e.g. RT-qPCR and serology) etc. High rates of diabetes and ischaemic heart disease comorbidities. Estimate 2% of this population will be admitted to hospital. Thus 500 severe cases.
Study Type: Retrospective(n=500)
Genetic analysis GWAS
https://www.covid19hg.org/partners/
http://www.genesandhealth.org/research-studies-approved/covid-19-genes-health-contributes-international-host-genetics-research
Category: Non-funding support
Description: One of the world’s largest community-based genetics studies, aiming to improve health among people of Pakistani and Bangladeshi heritage by analysing the genes and health of 100,000 local people. Genes & Health is a not-for-profit project.
1 Project.
The COVID-19 Host Genetics Initiative
Summary:
Genes & Health is a Partner of the global project "The COVID-19 Host Genetics Initiative".
In the framework of this project, the following study is being carried out:
Author: David van Heel
Research question: Our main research interest is a very early GWAS of severe covid cases. To address the question: does host genetics influence why a few get very severe disease, whereas many get aysymptomatic or mild disease?
Study design: 28675 existing Illumina GSAv3EA+MD genotyped (post QC) volunteers of British south Asian ethnicity. 5000 of these also whole exome sequenced. We will identify which of these touch UK hospital systems in real time. Data will include inpatient status and health record collected clinical details, pathology (e.g. RT-qPCR and serology) etc. High rates of diabetes and ischaemic heart disease comorbidities. Estimate 2% of this population will be admitted to hospital. Thus 500 severe cases.
Study Type: Retrospective(n=500)
Genetic analysis GWAS
https://www.covid19hg.org/partners/
http://www.genesandhealth.org/research-studies-approved/covid-19-genes-health-contributes-international-host-genetics-research
Technology:
COVID UK Funding&Support
Industry:
COVID UK Non-governmental Bodies
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
N/A
Register and Claim Ownership